The largest database of trusted experimental protocols

Fmmyalf

Manufactured by GenScript
Sourced in United States

The FMMYALF is a laboratory equipment used for analytical purposes. It serves as a tool for various scientific investigations and procedures. The core function of this equipment is to provide accurate measurements and data analysis capabilities to support research and development activities in a laboratory setting.

Automatically generated - may contain errors

2 protocols using fmmyalf

1

Neutrophil Activation and Surface Marker Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolated neutrophils were resuspended in PBS free from calcium and magnesium ions (PAA) at 10 × 106/mL and stimulated for 2 hours with 100 nM fMLF (Sigma-AldrichK) or 100 nM fMMYALF (GenScript) or pretreated for 10 minutes with 2.5 µM FPR1 antagonist CsH (Enzo Scientific) before stimulation. Neutrophils were incubated for 1 hour at 4°C with antibodies to Brilliant Violet 421 anti-human CD45 (Clone: HI30), APC/Fire 750 anti-human CD11b (activated) (Clone: CBRM1/5), Alexa Fluor 488 anti-human CD16 (Clone: 3G8), PE anti-human CD62L (Clone: DREG-56), and APC anti-human CD63 (Clone: H5C6) (BioLegend). Samples were washed and resuspended in 2% FCS and incubated briefly with DAPI (1:1000) before analysis using a BD Bioscience LSR Fortessa flow cytometer and FlowJo software (version 10.1).
+ Open protocol
+ Expand
2

Neutrophil Oxidative Burst Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neutrophils, plated at 3 × 105 cells/well, were incubated with a selective inhibitor of FPR1, cyclosporine H (CsH, 5 μM) for 30 min prior to the addition of stimuli, R848 (2.5 μg/ml), N-Formyl-Met-Leu-Phe (1 μM), formylated MT-ND6 peptide (1 μM) or plasma (1:100 dilution) for an additional 60 min. DHR 123 (0.5 μM), was added during last 30 min of incubation and ROS was analyzed by flow cytometry. Published sequence of formylated MT-ND6 peptide (f-MMYALF) [31 (link)] was synthesized commercially (GenScript USA, Inc.) and was tested as endotoxin-free.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!